Fibroids devoid of blood supply shrink and die
Follow-up study to evaluate the Long-term safety and efficacy of Darvadstrocel (Mesenchymal stem cell Treatment) in patients with perianal fistulizing crohns disease: ADMIRE-CD phase 3 randomized controlled trial [J]
316 Another Phase 2 study evaluating AXA1125 for the treatment of fatigue after COVID-19 infection has been completed, and a clinical study evaluating the safety, efficacy, and tolerability of AXA1125 in the treatment of nonalcoholic steatohepatitis (NASH) is ongoing
A metabolomic and lipidomic serum signature from nonhuman primates administered with a promising radiation countermeasure, gamma-tocotrienol
We recommend sticking with a routine for at least 90 days to truly gauge its impact
Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes